A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. PEG-MGDF is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-rhMGDF and polyethylene glycosylated recombinant human megakaryocyte growth and development factor.
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!